Receptor-mediated endocytosis is a Trojan horse in light-chain nephrotoxicity.
Nath
Karl A
KA
D000081247:CSK Tyrosine-Protein Kinase; D018932:Chemokine CCL2 / Q000378:metabolism; D004705:Endocytosis / Q000502:physiology*; D004847:Epithelial Cells / Q000473:pathology; D006801:Humans; D006861:Hydrogen Peroxide / Q000378:metabolism; D007147:Immunoglobulin Light Chains / Q000502:physiology*; D007674:Kidney Diseases / Q000503:physiopathology*; D007684:Kidney Tubules / Q000503:physiopathology; D026561:Low Density Lipoprotein Receptor-Related Protein-2 / Q000502:physiology*; D010084:Oxidation-Reduction; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000502:physiology*; D015398:Signal Transduction / Q000502:physiology; D019061:src-Family Kinases
C111835:CCL2 protein, human; D018932:Chemokine CCL2; D007147:Immunoglobulin Light Chains; D026561:Low Density Lipoprotein Receptor-Related Protein-2; D011956:Receptors, Cell Surface; C029486:intrinsic factor-cobalamin receptor; D006861:Hydrogen Peroxide; D011505:Protein-Tyrosine Kinases; D000081247:CSK Tyrosine-Protein Kinase; D019061:src-Family Kinases; C000631346:CSK protein, human